Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewHematologyImmunology Open Access | 10.1172/jci.insight.201160

Killer-cell Immunoglobulin-like Receptors define a potent effector program in human γδ T cells

Mahya Razmi,1 Yeganeh Almasi,1 Marilee Larrivée,1 Jonathan B. Angel,1 Alexandre Blais,1 and Zakia Djaoud1

1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

Find articles by Razmi, M. in: PubMed | Google Scholar

1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

Find articles by Almasi, Y. in: PubMed | Google Scholar

1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

Find articles by Larrivée, M. in: PubMed | Google Scholar

1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

Find articles by Angel, J. in: PubMed | Google Scholar

1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

Find articles by Blais, A. in: PubMed | Google Scholar

1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada

Find articles by Djaoud, Z. in: PubMed | Google Scholar

Published April 27, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.201160.
Copyright © 2026, Razmi et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published April 27, 2026 - Version history
View PDF
Abstract

Human γδ T cells are a rare but functionally diverse lymphocyte subset critical for tumor surveillance and antimicrobial immunity. Although they express natural killer (NK) cell-associated receptors such as Killer-cell Immunoglobulin-like Receptors (KIRs), the relevance of KIR expression on γδ T cells remains largely unexplored. Using flow cytometry, ATAC-seq and RNA-seq, we identified KIR expression as a marker that distinguished two functionally and molecularly distinct γδ T cell subsets. KIR⁺ γδ T cells exhibited an advanced, memory-like differentiation state characterized by heightened cytotoxicity, stable epigenetic remodeling and a predominant IFNγ-producing profile. In contrast, KIR⁻ γδ T cells maintained a naïve-like phenotype and preferentially produced IL-17 upon polarization. Notably, KIR+ γδ T cells were consistently observed across individuals but were significantly enriched in cytomegalovirus (CMV)-seropositive donors, suggesting that chronic antigenic stimulation could promote the emergence of KIR⁺ effector γδ T cells. These findings reveal a functional dichotomy in human γδ T cells defined by KIR expression, linking IFNγ-driven cytotoxicity with KIR⁺ cells and IL-17 production with KIR⁻ cells. This insight advances our understanding of γδ T cell heterogeneity and has implications for viral immunity, immune memory and the development of γδ T cell-based immunotherapies.

Graphical Abstract
graphical abstract
Supplemental material

View

Version history
  • Version 1 (April 27, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts